International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7799048
Original Article
A Study of Bacterial Vagenosis As A Causative Factor In Preterm Labour
 ,
 ,
Published
April 4, 2023
Abstract
Introduction: Preterm birth is the leading cause of perinatal morbidity and mortality. Bacterial vaginosis is a condition characterized by an alteration of the vaginal ecology in which the normal flora, dominated by lactobacilli, is replaced by a mixed bacterial flora which includes Gardnerella vaginalis, Mobiluncus species, Mycoplasma hominis. The prevalence of bacterial vaginosis among pregnant women varies from 6-32% in various studies. The classic symptoms of bacterial vaginosis include vaginal discharge and fishy odour. Its Complications of Bacterial vaginosis include spontaneous abortion, preterm labour and delivery, premature rupture of membranes. Aim of study: To assess the role of bacterial vaginosis in Preterm labour. Materials and methods: Prospective case control study done in all Antenatal cases with gestational age 28 weeks to 37 weeks attending the OPD or admitted in the department of OBG at Sri Siddartha Medical College, Tumakuru for duration of 24 months. Results: The incidence of Bacterial vaginosis in preterm labour cases was 31.2%. The mean gestational age who has gone into preterm labour was 32-36 weeks. Amsel’s criteria and Nugent score on examination, was statistically significant on comparison of cases and controls (p=0.0006). Conclusion: Bacterial vaginosis in pregnancy is associated with adverse pregnancy outcomes including preterm labour, low birth weight and puerperal sepsis. Thus screening for bacterial vaginosis in all pregnant women complaining of vaginal discharge is essential
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
253 Views
104 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved